News Headlines Article

FDA clears blood thinner for irregular heart beat
USA Today

Federal health officials have expanded approval of a blood thinning drug to millions of new patients with a common heart problem that can cause deadly strokes and blood clots. The Food and Drug Administration approved the drug Xarelto for patients with atrial fibrillation, a condition that causes the heart’s upper chambers to beat chaotically and ineffectively. About 2.2 million people in the U.S. have the condition, which is a leading cause of stroke.